Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification
- 16 August 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (35), 15631-15636
- https://doi.org/10.1073/pnas.1004021107
Abstract
Both increase and decrease of cardiac inward rectifier current (IK1) are associated with severe cardiac arrhythmias. Flecainide, a widely used antiarrhythmic drug, exhibits ventricular proarrhythmic effects while effectively controlling ventricular arrhythmias associated with mutations in the gene encoding Kir2.1 channels that decrease IK1 (Andersen syndrome). Here we characterize the electrophysiological and molecular basis of the flecainide-induced increase of the current generated by Kir2.1 channels (IKir2.1) and IK1 recorded in ventricular myocytes. Flecainide increases outward IKir2.1 generated by homotetrameric Kir2.1 channels by decreasing their affinity for intracellular polyamines, which reduces the inward rectification of the current. Flecainide interacts with the HI loop of the cytoplasmic domain of the channel, Cys311 being critical for the effect. This explains why flecainide does not increase IKir2.2 and IKir2.3, because Kir2.2 and Kir2.3 channels do not exhibit a Cys residue at the equivalent position. We further show that incubation with flecainide increases expression of functional Kir2.1 channels in the membrane, an effect also determined by Cys311. Indeed, flecainide pharmacologically rescues R67W, but not R218W, channel mutations found in Andersen syndrome patients. Moreover, our findings provide noteworthy clues about the structural determinants of the C terminus cytoplasmic domain of Kir2.1 channels involved in the control of gating and rectification.Keywords
This publication has 26 references indexed in Scilit:
- The mammalian KIR2.x inward rectifier ion channel family: expression pattern and pathophysiologyActa Physiologica, 2010
- Cardiac strong inward rectifier potassium channelsJournal of Molecular and Cellular Cardiology, 2010
- Inward rectifier potassium channels control rotor frequency in ventricular fibrillationHeart Rhythm, 2009
- Nitric Oxide Increases Cardiac I K1 by Nitrosylation of Cysteine 76 of Kir2.1 ChannelsCirculation Research, 2009
- Flecainide Suppresses Bidirectional Ventricular Tachycardia and Reverses Tachycardia‐Induced Cardiomyopathy in Andersen‐Tawil SyndromeJournal of Cardiovascular Electrophysiology, 2007
- Regional and tissue specific transcript signatures of ion channel genes in the non‐diseased human heartThe Journal of Physiology, 2007
- Unique Kir2.x Properties Determine Regional and Species Differences in the Cardiac Inward Rectifier K + CurrentCirculation Research, 2004
- Mechanism of Rectification in Inward-Rectifier K+ ChannelsAnnual Review of Physiology, 2004
- Comparison of cloned Kir2 channels with native inward rectifier K+ channels from guinea‐pig cardiomyocytesThe Journal of Physiology, 2001
- The Clinical Use of Oral FlecainideDrugs, 1985